Ishii Norihisa, Nagaoka Yuzuru, Mori Shuichi, Suzuki Koichi
Department of Bioregulation, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo. Japan.
Nihon Hansenbyo Gakkai Zasshi. 2006 Sep;75(3):239-48. doi: 10.5025/hansen.75.239.
The elimination of leprosy with the advent of multidrug therapy (MDT) is one of the success stories in public health. Elimination will be achieved in the regions of Western pacific and South-East Asia in near future. A biregional consultation between the WHO South-East Asia and Western Pacific regions was held in the end of 2004 in Manila, the Philippines. A strategy document was developed during the consultation, to sustain quality leprosy services in Asia and the Pacific beyond 2005, and to further reduce the leprosy burden. The main strategy involves timely detection of new cases, multidrug treatment, and the key element of integration of leprosy services into general health services.
随着多药联合疗法(MDT)的出现,麻风病的消除是公共卫生领域的成功案例之一。在不久的将来,西太平洋和东南亚地区将实现消除目标。2004年底,世界卫生组织东南亚和西太平洋地区在菲律宾马尼拉举行了一次双区域磋商会。磋商会期间制定了一份战略文件,以在2005年之后维持亚洲及太平洋地区高质量的麻风病服务,并进一步减轻麻风病负担。主要战略包括及时发现新病例、多药治疗,以及将麻风病服务纳入一般卫生服务的关键要素。